Literature DB >> 16341493

Spontaneous regression of hepatocellular carcinoma: report of a case.

Hiroshi Ohtani1, Osamu Yamazaki, Mitsuharu Matsuyama, Katsuhiko Horii, Sadatoshi Shimizu, Hiroko Oka, Hiroko Nebiki, Kiyohide Kioka, Osamu Kurai, Yasuko Kawasaki, Takao Manabe, Katsuko Murata, Ryoichi Matsuo, Takeshi Inoue.   

Abstract

A spontaneous regression of hepatocellular carcinoma is an extremely rare phenomenon. A 69-year-old Japanese man with hepatitis C virus-related chronic hepatitis presented with a liver tumor. We diagnosed the tumor to be hepatocellular carcinoma in the course of spontaneous regression, by imaging studies and changes in the tumor markers. Because the possible presence of viable cancer cells could not be ruled out, we recommended surgery. He refused all treatments at first, but finally agreed to undergo surgery about 10 months after presentation. A hepatectomy was performed. Histologically, no viable tumor cells were found. In our case, the vascularity of the tumor according to the imaging findings was followed up during the clinical course. The patient is now doing well and without any evidence of recurrence at 37 months after surgery.

Entities:  

Mesh:

Year:  2005        PMID: 16341493     DOI: 10.1007/s00595-005-3066-8

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  35 in total

1.  Spontaneous regression of hepatocellular carcinoma.

Authors:  H K van Halteren; J M Salemans; H Peters; G Vreugdenhil; W M Driessen
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

2.  Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis.

Authors:  K Ohba; K Omagari; T Nakamura; N Ikuno; S Saeki; I Matsuo; H Kinoshita; J Masuda; H Hazama; I Sakamoto; S Kohno
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

3.  Spontaneous regression of hepatocellular carcinoma.

Authors:  R C Ayres; D A Robertson; K C Dewbury; G H Millward-Sadler; C L Smith
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

4.  Long-term survival with tumor regression in androgen-induced liver tumors.

Authors:  G W McCaughan; M J Bilous; N D Gallagher
Journal:  Cancer       Date:  1985-12-01       Impact factor: 6.860

5.  Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.

Authors:  F L Johnson; K G Lerner; M Siegel; J R Feagler; P W Majerus; J R Hartmann; E D Thomas
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

6.  Spontaneous regression of hepatocellular carcinoma.

Authors:  S Markovic; V Ferlan-Marolt; Z Hlebanja
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864

7.  Spontaneous complete necrosis of hepatocellular carcinoma.

Authors:  Y Ozeki; N Matsubara; K Tateyama; M Kokubo; H Shimoji; M Katayama
Journal:  Am J Gastroenterol       Date:  1996-02       Impact factor: 10.864

8.  Spontaneous regression of recurrent hepatocellular carcinoma after TAE: possible mechanisms of immune mediation.

Authors:  T Nakai; T Shimomura; F Hirokawa
Journal:  Int J Clin Oncol       Date:  2001-06       Impact factor: 3.402

9.  Spontaneous regression of a hepatocellular carcinoma--a case report.

Authors:  M Suzuki; N Okazaki; M Yoshino; T Yoshida
Journal:  Hepatogastroenterology       Date:  1989-06

Review 10.  Spontaneous regression of hepatocellular carcinoma.

Authors:  M Grossmann; R Hoermann; M Weiss; K W Jauch; H Oertel; A Staebler; K Mann; D Engelhardt
Journal:  Am J Gastroenterol       Date:  1995-09       Impact factor: 10.864

View more
  19 in total

1.  Spontaneous regression of hepatocellular cancer: case report and review of literature.

Authors:  Navanshu Arora; Sheshadri Madhusudhana
Journal:  Gastrointest Cancer Res       Date:  2011-07

2.  Spontaneous regression of lung adenocarcinoma: Report of a case.

Authors:  Tomohiro Haruki; Hiroshige Nakamura; Yuji Taniguchi; Ken Miwa; Yoshin Adachi; Shinji Fujioka; Kohei Shomori; Hisao Ito
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

Review 3.  Spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature.

Authors:  Susana Oquiñena; Mercedes Iñarrairaegui; Juan J Vila; Felix Alegre; Jose M Zozaya; Bruno Sangro
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

4.  Exceptional patients and communication in cancer care-are we missing another survival factor?

Authors:  Moshe Frenkel; Joan C Engebretson; Sky Gross; Noemi E Peterson; Ariela Popper Giveon; Kenneth Sapire; Doron Hermoni
Journal:  Support Care Cancer       Date:  2016-05-12       Impact factor: 3.603

5.  Spontaneous Regression of Hepatocellular Carcinoma-a Case Report.

Authors:  Mohamed Aftab Alam; Debasish Das
Journal:  J Gastrointest Cancer       Date:  2017-06

6.  Spontaneous regression of multiple pulmonary recurrences of hepatocellular carcinoma after hepatectomy: report of a case.

Authors:  Norifumi Harimoto; Ken Shirabe; Kiyoshi Kajiyama; Tomonobu Gion; Masaru Takenaka; Takashi Nagaie; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-11-03       Impact factor: 2.549

7.  Spontaneous complete regression of hepatocellular carcinoma.

Authors:  Raul E Storey; Ana L Huerta; Amir Khan; Damian A Laber
Journal:  Med Oncol       Date:  2010-05-14       Impact factor: 3.064

Review 8.  Spontaneous regression of hepatocellular carcinoma is most often associated with tumour hypoxia or a systemic inflammatory response.

Authors:  Jonathan I Huz; Marcovalerio Melis; Umut Sarpel
Journal:  HPB (Oxford)       Date:  2012-05-15       Impact factor: 3.647

9.  Spontaneous regression of a biopsy confirmed hepatocellular carcinoma.

Authors:  Neil Bhardwaj; Mo Li; Timothy Price; Guy J Maddern
Journal:  BMJ Case Rep       Date:  2014-07-21

10.  A phase I/II trial of TAC-101, an oral synthetic retinoid, in patients with advanced hepatocellular carcinoma.

Authors:  Kimberly B Higginbotham; Richard Lozano; Thomas Brown; Yehuda Z Patt; Takashi Arima; James L Abbruzzese; Melanie B Thomas
Journal:  J Cancer Res Clin Oncol       Date:  2008-05-27       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.